Novartis AG (TSX:NVS)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 402.55 billion. The enterprise value is 436.50 billion.

Market Cap	402.55B
Enterprise Value	436.50B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.93%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.29%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 21.00 and the forward PE ratio is 17.21.

PE Ratio	21.00
Forward PE	17.21
PS Ratio	5.18
PB Ratio	6.31
P/TBV Ratio	n/a
P/FCF Ratio	16.69
P/OCF Ratio	15.34
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.19, with an EV/FCF ratio of 18.09.

EV / Earnings	22.77
EV / Sales	5.52
EV / EBITDA	13.19
EV / EBIT	16.48
EV / FCF	18.09

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.

Current Ratio	1.12
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	1.49
Debt / FCF	2.02
Interest Coverage	16.61

Financial Efficiency

Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 23.60%.

Return on Equity (ROE)	30.81%
Return on Assets (ROA)	11.14%
Return on Invested Capital (ROIC)	23.60%
Return on Capital Employed (ROCE)	22.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.03M
Profits Per Employee	254,743
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.27

Taxes

In the past 12 months, Novartis AG has paid 3.27 billion in taxes.

Income Tax	3.27B
Effective Tax Rate	14.59%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	25.57
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.22
Average Volume (20 Days)	1,570

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 77.71 billion and earned 19.17 billion in profits. Earnings per share was 9.80.

Revenue	77.71B
Gross Profit	59.03B
Operating Income	26.06B
Pretax Income	22.42B
Net Income	19.17B
EBITDA	32.18B
EBIT	26.06B
Earnings Per Share (EPS)	9.80

Balance Sheet

The company has 15.81 billion in cash and 48.62 billion in debt, with a net cash position of -32.80 billion.

Cash & Cash Equivalents	15.81B
Total Debt	48.62B
Net Cash	-32.80B
Net Cash Per Share	n/a
Equity (Book Value)	63.82B
Book Value Per Share	33.15
Working Capital	4.36B

Cash Flow

In the last 12 months, operating cash flow was 26.25 billion and capital expenditures -2.12 billion, giving a free cash flow of 24.13 billion.

Operating Cash Flow	26.25B
Capital Expenditures	-2.12B
Free Cash Flow	24.13B
FCF Per Share	n/a

Margins

Gross margin is 75.97%, with operating and profit margins of 33.53% and 24.67%.

Gross Margin	75.97%
Operating Margin	33.53%
Pretax Margin	28.85%
Profit Margin	24.67%
EBITDA Margin	41.42%
EBIT Margin	33.53%
FCF Margin	31.05%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	55.91%
Buyback Yield	3.93%
Shareholder Yield	3.93%
Earnings Yield	4.76%
FCF Yield	5.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.81 and a Piotroski F-Score of 7.

Altman Z-Score	3.81
Piotroski F-Score	7